Zobrazeno 1 - 10
of 99
pro vyhledávání: '"O. M. Kurbacheva"'
Autor:
E. L. Savlevich, O. M. Kurbacheva, A. V. Zurochka, E. S. Mitrofanova, Yu. S. Smolkin, E. V. Lyubimova
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 111-116 (2022)
Background. Leukotrienes play an important role in the pathogenesis of allergic rhinitis (AR) and eosinophilic type of chronic rhinosinusitis with nasal polyps (CRSwNP). There is a phenotype of CRSwNP in combination with AR, which has specifics of lo
Externí odkaz:
https://doaj.org/article/5159319eaae747649b81c0f50fe48155
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 15-23 (2022)
Introduction. Taking into account the prevalence of asthma and especially severe atopic asthma which requires carefully selected and expensive therapy, the appearance of the domestic biosimilar omalizumab among biological therapy drugs makes the choi
Externí odkaz:
https://doaj.org/article/ae96c5890b69489b92007e1dc3cd69d0
Autor:
E. L. Savlevich, A. V. Zurochka, O. M. Kurbacheva, V. I. Egorov, L. E. Gaganov, E. V. Lyubimova
Publikováno v:
Медицинская иммунология, Vol 24, Iss 1, Pp 147-156 (2022)
Chronic rhinosinusitis with nasal polyps (CRSP) is a heterogenous disease. We have earlier detected differences in severity of clinical manifestations, cellular infiltration degree shown in nasal polyps, of eosinophil-to-neutrophil ratio, efficacy of
Externí odkaz:
https://doaj.org/article/d4c6460b99694662b06fc35f01eeddf5
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 186-196 (2021)
The asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), atopic dermatitis (AD), eosinophilic esophagitis and other diseases based on T2-inflammation are a widespread in the world. It has led to the development of genetically engineered drugs a
Externí odkaz:
https://doaj.org/article/4d295209d37e4b69837baec73f655294
Autor:
D. S. Smirnov, O. M. Kurbacheva
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 92-98 (2021)
In recent years, there has been a significant increase in the prevalence of diseases of the nose and paranasal sinuses. Inflammatory diseases of the mucous membrane nasal cavities (rhinitis) are most commonly characterized as a syndrome in which the
Externí odkaz:
https://doaj.org/article/a05fcae820b54ec3b70285eee1fa614f
Autor:
O. M. Kurbacheva, M. A. Galitskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 38-49 (2019)
The article describes a modern approach to the use of anti-IgE therapy for allergic bronchial asthma and conditions associated with this disease. The humanized monoclonal anti-IgE antibody, Omalizumab (Xolar®), is a promising treatment for allergic
Externí odkaz:
https://doaj.org/article/de664d019a924121a62965390a4e6cd8
Autor:
E. L. Savlevich, O. M. Kurbacheva
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 38-43 (2019)
Both allergic rhinitis (AR) and polypous rhinosinusitis (PRS) are a serious problem in context of their impact on quality of life, the risk of complications, overlay of bronchial asthma (BA) and medical control of these diseases. In most cases, T2 ty
Externí odkaz:
https://doaj.org/article/2895830bfdcb492ca46427ebf2eb5b08
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 84-91 (2015)
The past 30 years have seen an overall increase in the prevalence of allergic diseases (AD) among which allergic rhinitis (AR) is one of the most common. The disease produces a significant impact on physical and mental health of patients, and is a he
Externí odkaz:
https://doaj.org/article/eeeff03ea313490ba12689df76f53823
Publikováno v:
Медицинский совет, Vol 0, Iss 3-2, Pp 10-19 (2013)
Today, allergy can easily be called a disease of the XXI century. Patients are increasingly complaining about various forms of allergy. Allergy symptoms are varied and diverse, as are the ways of treatment of allergic diseases. According to the stati
Externí odkaz:
https://doaj.org/article/966e6fd2466341cfb3fd2d5d940821b4
Autor:
A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, O. S. Vasil’eva, N. A. Geppe, G. L. Ignatova, N. P. Knyazheskaya, A. B. Malakhov, N. I. Meshcheryakova, N. M. Nenasheva, R. S. Fassakhov, R. M. Khaitov, N. I. Il’ina, O. M. Kurbacheva, N. G. Astafieva, I. V. Demko, D. S. Fomina, L. S. Namazova-Baranova, A. A. Baranov, E. A. Vishneva, G. A. Novik
Publikováno v:
PULMONOLOGIYA. 32:393-447
Bronchial asthma is a heterogeneous disease that requires identification of its phenotype and a personalized approach to therapy. At the same time, despite a wide range of therapeutic options, many patients with asthma cannot achieve control over the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebeb06b8468245cfe8cea800e6ea8d2e
https://doi.org/10.18093/0869-0189-2022-32-3-393-447
https://doi.org/10.18093/0869-0189-2022-32-3-393-447